dc.creator | Vavougios G., Zarogiannis S.G., Doskas T. | en |
dc.date.accessioned | 2023-01-31T10:29:56Z | |
dc.date.available | 2023-01-31T10:29:56Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1016/j.msard.2018.02.027 | |
dc.identifier.issn | 22110348 | |
dc.identifier.uri | http://hdl.handle.net/11615/80518 | |
dc.description.abstract | Recent research has outlined that Dimethyl Fumarate (DMF) functions as a gene regulator via multiple pathways, critical among which is the NRF2 cytoprotective cascade. PARK7/DJ-1 is a multifunctional protein that acts as a redox sensor and effector of multiple cytoprotective pathways, including NRF2. Specifically, it prevents the association of NRF2 with its inhibitor KEAP1, allowing NRF2 to enter the nucleus and mediate cytoprotective and antioxidant cascades. It is our hypothesis that while the NRF2-KEAP1 inhibitory complex is reported the main pharmacological target for DMF's NRF dependent functions, no study to date has explored the effects of DMF on DJ-1's expression, and vice-versa, the possibility of a regulatory inadequacy in the upstream, oxidant-responsive DJ-1 activator of the NRF2 cascade. © 2018 Elsevier B.V. | en |
dc.language.iso | en | en |
dc.source | Multiple Sclerosis and Related Disorders | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043376966&doi=10.1016%2fj.msard.2018.02.027&partnerID=40&md5=c84fca1ec5ddeaeccb734b2ef83b3e68 | |
dc.subject | chemokine receptor CXCR4 | en |
dc.subject | fumaric acid dimethyl ester | en |
dc.subject | immunoglobulin enhancer binding protein | en |
dc.subject | mammalian target of rapamycin | en |
dc.subject | phosphatidylinositol 3 kinase | en |
dc.subject | phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase | en |
dc.subject | protein deglycase DJ-1 | en |
dc.subject | reactive oxygen metabolite | en |
dc.subject | transcription factor Nrf2 | en |
dc.subject | fumaric acid dimethyl ester | en |
dc.subject | immunosuppressive agent | en |
dc.subject | protein deglycase DJ-1 | en |
dc.subject | transcription factor Nrf2 | en |
dc.subject | cell fate | en |
dc.subject | cellular immunity | en |
dc.subject | cytokine response | en |
dc.subject | demyelinating disease | en |
dc.subject | disease association | en |
dc.subject | human | en |
dc.subject | immune response | en |
dc.subject | immunomodulation | en |
dc.subject | malignant neoplasm | en |
dc.subject | nonhuman | en |
dc.subject | oxidative stress | en |
dc.subject | protein binding | en |
dc.subject | protein expression | en |
dc.subject | protein function | en |
dc.subject | protein protein interaction | en |
dc.subject | protein targeting | en |
dc.subject | Review | en |
dc.subject | signal transduction | en |
dc.subject | animal | en |
dc.subject | metabolism | en |
dc.subject | multiple sclerosis | en |
dc.subject | neoplasm | en |
dc.subject | Animals | en |
dc.subject | Dimethyl Fumarate | en |
dc.subject | Humans | en |
dc.subject | Immunosuppressive Agents | en |
dc.subject | Multiple Sclerosis | en |
dc.subject | Neoplasms | en |
dc.subject | NF-E2-Related Factor 2 | en |
dc.subject | Protein Deglycase DJ-1 | en |
dc.subject | Elsevier B.V. | en |
dc.title | The putative interplay between DJ-1/NRF2 and Dimethyl Fumarate: A potentially important pharmacological target | en |
dc.type | other | en |